skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Review of photodynamic therapy in actinic keratosis and basal cell carcinoma

Review

(2177) Views  (613) Full article downloads

Authors: Marica B Ericson, Ann-Marie Wennberg, Olle Larkö

Published Date March 2008 Volume 2008:4(1) Pages 1 - 9
DOI: http://dx.doi.org/10.2147/TCRM.S1769

Marica B Ericson1,2, Ann-Marie Wennberg1, Olle Larkö1

1Department of Dermatology; 2Department of Physics, Göteborg University, Göteborg, Sweden

Abstract: The number of non-melanoma skin cancers is increasing worldwide, and so also the demand for effective treatment modalities. Topical photodynamic therapy (PDT) using aminolaevulinic acid or its methyl ester has recently become good treatment options for actinic keratosis and basal cell carcinoma; especielly when treating large areas and areas with field cancerization. The cure rates are usually good, and the cosmetic outcomes excellent. The only major side effect reported is the pain experienced by the patients during treatment. This review covers the fundamental aspects of topical PDT and its application for treatment of actinic keratosis and basal cell carcinoma. Both potentials and limitations will be reviewed, as well as some recent development within the field.

Keywords: photodynamic therapy, actinic keratosis, basal cell carcinoma








Readers of this article also read:

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy
Critical appraisal of medical devices in the management of cerebrovascular disease
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients
Medical treatment of Cushing's disease: Overview and recent findings
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Activities of key glycolytic enzymes in the plasma of Saudi autistic patients
The role of rasagiline in the treatment of Parkinson’s disease
Corrigendum